239 related articles for article (PubMed ID: 23529928)
1. The C-type lectin receptor CLEC4M binds, internalizes, and clears von Willebrand factor and contributes to the variation in plasma von Willebrand factor levels.
Rydz N; Swystun LL; Notley C; Paterson AD; Riches JJ; Sponagle K; Boonyawat B; Montgomery RR; James PD; Lillicrap D
Blood; 2013 Jun; 121(26):5228-37. PubMed ID: 23529928
[TBL] [Abstract][Full Text] [Related]
2. Genetic variation in the C-type lectin receptor CLEC4M in type 1 von Willebrand Disease patients.
Manderstedt E; Lind-Halldén C; Lethagen S; Halldén C
PLoS One; 2018; 13(2):e0192024. PubMed ID: 29389944
[TBL] [Abstract][Full Text] [Related]
3. CLEC4M and STXBP5 gene variations contribute to von Willebrand factor level variation in von Willebrand disease.
Sanders YV; van der Bom JG; Isaacs A; Cnossen MH; de Maat MP; Laros-van Gorkom BA; Fijnvandraat K; Meijer K; van Duijn CM; Mauser-Bunschoten EP; Eikenboom J; Leebeek FW;
J Thromb Haemost; 2015 Jun; 13(6):956-66. PubMed ID: 25832887
[TBL] [Abstract][Full Text] [Related]
4. The endothelial lectin clearance receptor CLEC4M binds and internalizes factor VIII in a VWF-dependent and independent manner.
Swystun LL; Notley C; Georgescu I; Lai JD; Nesbitt K; James PD; Lillicrap D
J Thromb Haemost; 2019 Apr; 17(4):681-694. PubMed ID: 30740857
[TBL] [Abstract][Full Text] [Related]
5. Family studies and prenatal diagnosis in severe von Willebrand disease by polymerase chain reaction amplification of a variable number tandem repeat region of the von Willebrand factor gene.
Peake IR; Bowen D; Bignell P; Liddell MB; Sadler JE; Standen G; Bloom AL
Blood; 1990 Aug; 76(3):555-61. PubMed ID: 2378985
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide studies of von Willebrand factor propeptide identify loci contributing to variation in propeptide levels and von Willebrand factor clearance.
Ozel AB; McGee B; Siemieniak D; Jacobi PM; Haberichter SL; Brody LC; Mills JL; Molloy AM; Ginsburg D; Li JZ; Desch KC
J Thromb Haemost; 2016 Sep; 14(9):1888-98. PubMed ID: 27359253
[TBL] [Abstract][Full Text] [Related]
7. Gain-of-function GPIb ELISA assay for VWF activity in the Zimmerman Program for the Molecular and Clinical Biology of VWD.
Flood VH; Gill JC; Morateck PA; Christopherson PA; Friedman KD; Haberichter SL; Hoffmann RG; Montgomery RR
Blood; 2011 Feb; 117(6):e67-74. PubMed ID: 21148813
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of an automated method for measuring von Willebrand factor activity in clinical samples without ristocetin.
Graf L; Moffat KA; Carlino SA; Chan AK; Iorio A; Giulivi A; Hayward CP
Int J Lab Hematol; 2014 Jun; 36(3):341-51. PubMed ID: 24750681
[TBL] [Abstract][Full Text] [Related]
9. The contribution of the sinusoidal endothelial cell receptors CLEC4M, stabilin-2, and SCARA5 to VWF-FVIII clearance in thrombosis and hemostasis.
Swystun LL; Michels A; Lillicrap D
J Thromb Haemost; 2023 Aug; 21(8):2007-2019. PubMed ID: 37085036
[TBL] [Abstract][Full Text] [Related]
10. Measurement of von Willebrand factor binding to a recombinant fragment of glycoprotein Ibalpha in an enzyme-linked immunosorbent assay-based method: performances in patients with type 2B von Willebrand disease.
Caron C; Hilbert L; Vanhoorelbeke K; Deckmyn H; Goudemand J; Mazurier C
Br J Haematol; 2006 Jun; 133(6):655-63. PubMed ID: 16704443
[TBL] [Abstract][Full Text] [Related]
11. Unraveling the Influence of Common von Willebrand factor variants on von Willebrand Disease Phenotype: An Exploratory Study on the Molecular and Clinical Profile of von Willebrand Disease in Spain Cohort.
Borràs N; Garcia-Martínez I; Batlle J; Pérez-Rodríguez A; Parra R; Altisent C; López-Fernández MF; Costa Pinto J; Batlle-López F; Cid AR; Bonanad S; Cabrera N; Moret A; Mingot-Castellano ME; Navarro N; Pérez-Montes R; Marcellini S; Moreto A; Herrero S; Soto I; Fernández-Mosteirín N; Jiménez-Yuste V; Alonso N; de Andrés-Jacob A; Fontanes E; Campos R; Paloma MJ; Bermejo N; Berrueco R; Mateo J; Arribalzaga K; Marco P; Palomo Á; Castro Quismondo N; Iñigo B; Del Mar Nieto M; Vidal R; Martínez MP; Aguinaco R; Tenorio M; Ferreiro M; García-Frade J; Rodríguez-Huerta AM; Cuesta J; Rodríguez-González R; García-Candel F; Dobón M; Aguilar C; Corrales I; Vidal F
Thromb Haemost; 2020 Mar; 120(3):437-448. PubMed ID: 32135566
[TBL] [Abstract][Full Text] [Related]
12. A novel modifier gene for plasma von Willebrand factor level maps to distal mouse chromosome 11.
Mohlke KL; Nichols WC; Westrick RJ; Novak EK; Cooney KA; Swank RT; Ginsburg D
Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15352-7. PubMed ID: 8986815
[TBL] [Abstract][Full Text] [Related]
13. Genetic linkage and association analysis in type 1 von Willebrand disease: results from the Canadian type 1 VWD study.
James PD; Paterson AD; Notley C; Cameron C; Hegadorn C; Tinlin S; Brown C; O'Brien L; Leggo J; Lillicrap D;
J Thromb Haemost; 2006 Apr; 4(4):783-92. PubMed ID: 16634747
[TBL] [Abstract][Full Text] [Related]
14. Comparison between von Willebrand factor (VWF) and VWF antigen II in normal individuals and patients with von Willebrand disease.
de Romeuf C; Mazurier C
Thromb Haemost; 1998 Jul; 80(1):37-41. PubMed ID: 9684782
[TBL] [Abstract][Full Text] [Related]
15. Von Willebrand factor 1 and factor 2 alleles (intron 40) are suitable markers for carrier detection in von Willebrand disease families in the Indian population.
Trasi S; Mohanty D; Pathare A; Shetty S; Ghosh K
Acta Haematol; 2006; 115(1-2):64-7. PubMed ID: 16424652
[TBL] [Abstract][Full Text] [Related]
16. Comparison of an automated chemiluminescent assay to a manual ELISA assay for determination of von Willebrand Factor collagen binding activity on VWD plasma patients previously diagnosed through molecular analysis of VWF.
Jousselme E; Jourdy Y; Rugeri L; Négrier C; Nougier C
Int J Lab Hematol; 2018 Feb; 40(1):77-83. PubMed ID: 28980759
[TBL] [Abstract][Full Text] [Related]
17. An investigation of the von Willebrand factor genotype in UK patients diagnosed to have type 1 von Willebrand disease.
Cumming A; Grundy P; Keeney S; Lester W; Enayat S; Guilliatt A; Bowen D; Pasi J; Keeling D; Hill F; Bolton-Maggs PH; Hay C; Collins P;
Thromb Haemost; 2006 Nov; 96(5):630-41. PubMed ID: 17080221
[TBL] [Abstract][Full Text] [Related]
18. Polymerase chain reaction amplification of two polymorphic simple repeat sequences within the von Willebrand factor gene: application to family studies in von Willebrand disease.
Cumming AM; Armstrong JG; Pendry K; Burn AM; Wensley RT
Hum Genet; 1992 May; 89(2):194-8. PubMed ID: 1587530
[TBL] [Abstract][Full Text] [Related]
19. Desmopressin therapy to assist the functional identification and characterisation of von Willebrand disease: differential utility from combining two (VWF:CB and VWF:RCo) von Willebrand factor activity assays?
Favaloro EJ; Thom J; Patterson D; Just S; Dixon T; Koutts J; Baccala M; Rowell J; Baker R
Thromb Res; 2009 Apr; 123(6):862-8. PubMed ID: 19064279
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis of von Willebrand disease type 2N: a simplified method for measurement of factor VIII binding to von Willebrand factor.
Miller CH; Kelley L; Green D
Am J Hematol; 1998 Aug; 58(4):311-8. PubMed ID: 9692396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
